Chris Elliott

With great power comes great responsibility. As ESG momentum intensifies, the scrutiny over the pharmaceutical sector’s role in society is increasing. How 'pharma' evolves to meet fresh ESG challenges will present challenges and opportunities for the...

Four new ratings added

Will join Chris Elliott as co-portfolio manager on new fund

Improving governance and engagement key to reforms

Drinks giant dropped due to excessive 'valuation risk'

New UCITS product to target long-term total returns

No single internal structure suits all businesses

Fund outeperforms two years on from launch

Which companies are bridging the generation gap?

Consumer goods and tech companies get support